| Market Capitalization (Millions $) |
107,872 |
| Shares
Outstanding (Millions) |
1,562 |
| Employees |
83,100 |
| Revenues (TTM) (Millions $) |
45,811 |
| Net Income (TTM) (Millions $) |
5,961 |
| Cash Flow (TTM) (Millions $) |
5,840 |
| Capital Exp. (TTM) (Millions $) |
1,361 |
Astrazeneca Plc
AstraZeneca Plc is a global pharmaceutical and biopharmaceutical company, headquartered in Cambridge, England, with research and development centers in Sweden, the United States and China. It is one of the largest pharmaceutical companies in the world and operates in over 100 countries.
The company was formed in 1999 through the merger of two established pharmaceutical companies, Astra AB of Sweden and Zeneca Group plc of the UK. AstraZeneca specializes in the development and marketing of prescription drugs for a variety of medical conditions, including cardiovascular, respiratory, and oncology diseases, among others.
AstraZeneca has a strong commitment to innovation, with a significant portion of its revenue reinvested into research and development. It operates several research and development centers worldwide, focusing on therapeutic areas that include oncology, respiratory, and cardiovascular disease. The company's research and development efforts have led to the development of a wide range of life-saving drugs, such as Seloken, Atacand, Crestor, Symbicort, and Imfinzi.
AstraZeneca is also committed to sustainability and to providing a positive impact on the environment and society. The company operates with a strong emphasis on environmental responsibility and sustainability, working towards the reduction of greenhouse gas emissions, water conservation, and responsible waste management. The company is also committed to providing access to affordable medicines to underserved populations.
In 2020, AstraZeneca became a household name due to its success in developing a vaccine for COVID-19 in collaboration with the University of Oxford. The vaccine, which requires two doses, has been authorized in many countries around the world and is playing a crucial role in the global fight against the pandemic.
AstraZeneca is publicly traded on the London Stock Exchange and is a constituent of the FTSE 100 index. It is currently led by CEO Pascal Soriot. As of 2021, the company had approximately 76,100 employees worldwide and reported revenue of $26.6 billion.
Company Address: 1 Francis Crick Avenue Cambridge 0
Company Phone Number: 3749 5000 Stock Exchange / Ticker: NASDAQ AZN
|
